[go: up one dir, main page]

CA1332568C - Cosmetic composition - Google Patents

Cosmetic composition

Info

Publication number
CA1332568C
CA1332568C CA000610359A CA610359A CA1332568C CA 1332568 C CA1332568 C CA 1332568C CA 000610359 A CA000610359 A CA 000610359A CA 610359 A CA610359 A CA 610359A CA 1332568 C CA1332568 C CA 1332568C
Authority
CA
Canada
Prior art keywords
acid
emulsion
oil
emulsion according
chosen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000610359A
Other languages
French (fr)
Inventor
Mavis Claire Pereira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10643292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1332568(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever PLC filed Critical Unilever PLC
Application granted granted Critical
Publication of CA1332568C publication Critical patent/CA1332568C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ABSTRACT

An emulsion suitable for topical application to human skin or hair comprises, in addition to water from 0.01 to 20%
by weight of a skin benefit ingredient, preferably a 2-hydroxyalkanoic acid having from-3 to 20 carbon atoms, or a salt thereof; from 0.1 to 20% by weight of polyoxyethylene-21-stearyl ether, as a principle emulsifier and from 0.5 to 70% by weight of an emollient oil.

Description

" ' .
" ; ~ "

~ J.3087 i COSM~TIC COMPOSITION

~, :
FI~LD OF INVENTION

3 The invention relates to emulsions which are suitable for topical application to skin or hair, more particularly to emulsions comprisin~ a 2-hydroxyalkanoic acid or a salt thereof or other skin benefit agents.

BACKGROUND AN~ PRIOR ART
,j .
The use of 2-hydroxyoctanoic acid in products for topical application to human skin has been proposed in ` EP-A 0 007 785 (Unilever). There remains, however, a problem in delivering this~acid to subcutaneous regions of the skin, where its benefit of increasing the extensibility of stratum corneum is maximised.
~, ` An attempt has subsequently been made, as described ;
i in EP-A-0 117 080 (Unilever), to improve the delivery of .~, :
.; ~
., ~, ., '~ .

:-, d 1 332~68 - 2 - J.3087 amphiphylic compounds such as 2-hydroxyoctanoic acid by the use of an emulsifier having an average HLB value of from 5 to 11, which is capable with water of forming a gel phase having an X-ray reflection of from 0.37 to 0.44, and which permits substantially no co-crystallisation with the amphiphylic compound. Although improved delivery of 2-hydroxyoctanoic acid has been demonstrated with compositions based on the emulsifier system disclosed in this reference, their shelf life is limited, in that syneresis tends to occur after storage at 45C lthe normal maximum storage temperature for testing stability) for only a few wee~s. Such limitations as to storage tability virtually rule out the possibility of employing such systems in products where manv weeks or months may elapse during storage prior to sale or prior to use by the consumer.

We have now discovered that bv selecting a special emulsifier not previously proposed for use with 2-hydroxyoctanoic acid and related substances, that emulsions can be prepared which are completely stable during storage at 45CC for at least 12 months, or longer at lower storage temperatures, and which also show excellent freeze-thaw stability following cooling to -22C, thus pro~Tiding an answer to a lonq felt need for superior storage stability characteristics. Furthermore, emulsions containing certain other skin benefit agents in place of or in addition to 2-hydroxyalkanoic acids such as 2-hydroxyoctanoic acid, also benefit from exceptional ; 30 storage stability when using the special emulsifier.

DEFINITION OF T~E INVENTION
' , Accordingly, the invention provides an emulsion suitable for topical application to human skin or hair, which comprises in addition to water:

~ .

. , . .................. : -, ~ - ...... .. . ,~ ~ . ~ ,, .~ .
. . , - . ~ . .. ... ~ i: : -:::: : ~ :
- 3 - J.3087 i) from 0.01 to 20~3 by weight of a skin benefit ingredient chosen from:

Retinoic acid Retinyl palmitate Ascorbic acid Ascorbyl palmitate Tocopherol Tocopherol acetate 3 10 Pyroglutamic acid and salts thereof ~ Amino acids ', Sunscreens ' Hyaluronic acid and salts thereof Perfluoropolyether ~ 15 Hydrocortisone acetate and : a 2-hydroxyalkanoic acid having from 3 to 20 carbon ' atoms, or a salt thereof; and mixtures thereof:
:
, 20 ii) from 0.1 to 20% by weight of . polyoxvethylene-21-stearyl ether as a principle , emulsifier; and ' iii) from 0.5 to 70% by weight of an emollient oil.
DISCLOSURE OF THF. INVENTION
.-.
,. The Emulsion : 30 The emulsion according to the invention will normally contain an aqueous phase and an oily phase and will . comprise a selected skin benefit ingredient, a special :; emulsifier and an emollient oil.

.`. 35 The emulsion preferably possesses a continuous aqueous phase in which case it is an oil-in-water ~:i emulsion, the aqueous phase comprising from 98 to 60~ by - 4 - J.3087 volume and the oily phase from 2 to 40% by volume of the emulsion.

Alternatively, the emulsion can possess a continuous oily phase, in which case it is a water-in-oil emulsion, the aqueous phase usually comprising from 25 to 70% by volume and the oily phase from 75 to 30% by volume of the emulsion. ~owever, the emulsion can also be a high internal phase water-in-oil emulsion, in which case the aqueous phase can compri~e up to 98% by volume of the emulsion, the nily ph~se then formina as little as 2% by volume of the emulsion.

The form of the emulsion, whether oil-in-water or ~ater-in-oil, will largely depend upon the average ~L~
value of the emulsifier(s) which is employed, values greater than 8 generally giving rise to oil-in-water emulsions and values of up to 8 generally givina rise to water-in-oil emulsions.
The Emulsion Inaredients (i) The skin benefit inaredient . .
The emulsion according to the invention comprises a skin benefit ingredient chosen from Retinoic acid Retinyl palmitate Ascorbic acid Ascorbyl palmitate Tocopherol Tocopherol acetate Pyroglutamic acid and salts thereof `~ ~
1 33~568 - 5 - J.3087 Amino acids ' Sunscreens j Hyaluronic acid and salts ther~of Perfluoropolyether 5Hvdrocortisone acetate and a 2-hydroxyalkanoic acid having from 3 to 20 carbon atoms, or a salt thereof; and mixtures thereof;

The emulsion can also comprise a mixture of two or more skin benefit ingredients.
:
Particularly preferred examples of amino acids include:
::
~ 15 glycine :` alanine valine ., leucine isoleucine phenylalanine tyrosine proline :: hy~roxyproline serine - 25 threonine `j cysteine cvstine ~ methionine i tryptophan .~ 30 aspartic acid x glutamic acid . arginine ~`. lysine, and `~ histidine.
. 35 ', :." ;:
.

` ^` - 1 332568 - 6 - J.3087 The amount of amino acid that can be employed in accordance with the invention will normally be from 0.01 to 20%, preferably from 0.1 to 10% by weight of the emulsion.
Particularly preferred examples of sunscreen active ingredients include:

p-Aminobenzoic acid Ethyl dihydroxypropyl p-aminobenzoic acid (such as Amerscreen P) Glyceryl p-aminobenzoic acid (such as Escalol 106) 2,4-Dihydroxy benzophenone (such as Uvinul 400) 2-Ethoxyethyl-p-methoxycinnamate (such as Giv ~an F) Di-ethanolamine p-methoxycinnamate (such as Parsol Hydro) 2-Ethylhexyl salicylate (such as Sun Arome WMO) Homomenthyl salicvlate (such as Filtrosol A) 2-Phenylbenzimidazole-5-sulphonic acid ~such as Eusolex ` 232) - 20 Octyl methoxycinnamate (such as Parsol MCX).
. 3-~4-Methylbenzylidine) camphor (such as Eusolex 6300) 2-Hydroxy-4-methoxy benzophenone (such as Eusolex 4360 ~utylmethoxydibenzoylmethane (such as Parsol 1789) 4-isopropyl dibenzoylmethane (such as Eusolex 8n20).

"
; The amount of the sunscreen active ingredient that can ` optionally be employed in accordance with the invention, as a therapeutically effective amount, will normally be from 0.01 to 10%, preferably from 0.1 to 5% and most preferably from 1 to 5% by weight of the emulsion.

Particularly preferred examples of 2-hydroxyalkanoic acids include 2-hvdroxypropanoic acid, 2-hydroxyhexanoic .

`"- 1 3325~8 - 7 - J.3087 acid and 2-hydroxyoctanoic acid. Further examples include 2-hvdroxy-N-butanoic acid, 2-hydroxydecanoic acid, 2-hydroxydodecanoic acid and 2-hydroxyoctadecanoiC acid.

Examples of salts of the above 2-hydroxyalkanoic acids are the sodium, potassium and triethanolamine salts, although it is to be understood that other metallic, ammonium or alkanolammonium salts are useful.

The emulsion according to the invention can comprise mixtures of 2-hydroxyalkanoic acids and/or salts and/or an acid soap complex thereof.

The most preferred 2-hydroxyalkanoic acid is 2-hvdroxyoctanoic acid or its acid soap complex having the empirical formula where M is a cation chosen from sodium, potassium and ammonium.

The amount of skin benefit ingredient present in the emulsion accordin~ to the invention is usually from 0.01 to 20%, preferably from 0.1 to 10% by weight of the emulsion.

(ii) The Principal Emulsifier The emulsion accordin~ to the invention comprises as the principal emulsifier polyoxyethylene-21-stearyl ether, also known as polyoxyethylene-21-stearyl alcohol, an example of which is Brij 721 (available from ICI). This emulsifier has an HLB value of about 15.5 and if used alone will yield an oil-in-water emulsion.
~ ~le~o~cs 7~ra~ rk - - 8 - J.3087 The amount of polyoxyethylene-21-stearyl ether present in the emulsion according to the invention is usually from 0.1 to 20%, preferahlv from 0.5 to 10% by weight of the emulsion.

(iii) ~he Emollient Oil ., The emulsion according to the invention comprises an emollient oil, that is an oily substance that is substantially insoluble, or only slightly soluble in water, and which usually constitutes the major ingredient of the ~ily phase of the emulsion.

Examples of emollient oils include the following:
` 15 Hydrocarbon oils and waxes: examples of which include, mineral oil, petrolatum, paraffin, ozokerite, microcrys~alline wax, polyethylene and perhydrosqualene q (squalane).
' 20 , 2. Silicone oils: examples of which include, dimethyl polysiloxanes, methylphenyl polysiloxanes.

3. Triglyceride esters: examples of which include, vegetable and animal fats and oils, such as caprylic and capric triglycerol (available as Migliol 812), wheatgerm oil, apricot kernel oil, avocado oil, sunflower seed oil, arnica oil, evenlng primrose oil and jojoba oil.

4. Acetoglyceride esters: examples of which include, acetylated monoglycerides.

- 5. Alkyl esters: examples of which include, methyl, isopropyl, and butyl esters of fatty acids; hexyl laurate, isohexyl laurate, isopropyl myristate, isopropyl - palmitate, flecyl oleate, isodecyl oleate, hexadecyl ..

:

`~

- 9 - J.3087 (isocetyl! stearate, diisopropyl adipate, diisohexyl adipate, dihexadecyl adipate, diisopropyl sebacate, lauryl lactate, myristyl lactate, and cetyl lactate.

6. Alkenyl esters: examples of which include, oleyl myristate, oleyl stearate, and oleyl oleate.

7. Fatty acids: examples of which include, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, linolenic, ~ -linolenic, ricinoleic, arachidic, behenic, erucic, and lanolin acids.
8. Fatty alcohols: examples of which include, lauryl, myristyl, cetyl, hexadecyl (isocetyl), stearyl, isostearyl, hydroxystearyl, oleyl, ricinoleyl, behenyl and erucyl alcohols, and 2-octyl dodecanol.
9. Fatty alcohol ethers: examples of which include, ethoxylated lauryl, cetyl, stearyl, isostearyl, oleyl, and lanolin alcohols; and cholesterol; propoxylated cetyl, oleyl, and lanolin alcohols; and also polypropylene-15-stearyl ether.

lO. Ether-esters: examples of which include, fatty acid esters of ethoxylated fatty alcohols.
;

11. Lanolin and lanolin derivatives : examples of which ~-include, lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids and acetylated lanolin derivatives.

12. ax esters: examples of which include, lanolin (de-oiled wax fraction), beeswax, spermaceti, myristyl myristate, stearyl stearate.

, .~
:

s~ ~
- 10 - J.3087 13. Beeswax derivatives: examples of which include, polyoxyethylene sorbitol beeswax. These are reaction products of beeswax with ethoxylated sorbitol of varying ethylene oxide content, forming a mixture of ether-esters.

14. Vegetable waxes: examples of which include, carnauba, candelilla.

15. PhoPholipids: examples of which include, lecithin and derivatives.

16. Sterols: Cholesterol, cholesterol fattv acid esters.

The amount of emollient oil present in the emulsion according to the invention is usually from 0.5 to 70%, prefera~ly from 1 to 60% bv weight of the emulsion.
;

Other emulsion ingredients (i) Secondary Emulsifiers The emulsion according to the invention can also comprise one or more secondary emulsifiers, in addition the principle emulsifier polyoxyethylene-21-stearyl ether.

Examples of secondary emulsifiers include:
HLB value BRIJ 72 (Polyoxyethylene-2-stearyl ether) 4.9 BRIJ 52 (Polyoxyethylene-2-cetyl ether) 5.3 `~ The presence of a secondary emulsifier can result in the formation of a water-in-oil emulsion, if the average HLB
of all emulsifers present does not exceed 8. The -`` 1 332568 - 11 - J.3087 preferred emulsions according to the invention are, however oil-in-water em~llsions.
.
The amount of secondary emulsifiers that optionally can be present in the emulsion according to the invention is up to 20%, preferably from n . 1 to 10% by weight of the emulsion.

(ii) Thickeners The emulsion accordina to the invention can also optionally comprise a thickener, examples of which ` include:

- 15 xanthan gum, such as Rhodopol 23, aluminium starch octenylsuccinate, such as Dry Flo starch, carboxyvinyl polymer, such as Carbopol 938, 940 & 941 . carboxymethyl cellulose, and ;, 20 hydroxypropvlmethyl cellulose.

The amount of thickener that optionally can be present in the emulsion according to the invention will depend upon which thickener is chosen, the amount being that conventionally employed as recommended by the respective manufacturer. Generally, the amount of thickener will be up to 10%, preferably from 0.1 to 5% by weight of the emulsion.
,. ~ . .
(iii) Skin Delivery Enhancers ` The emulsion according to the invention can also ;~ optionally comprise one or more substances to enhance ;~ deliverv of the skin benefit ingredient to the stratum ``~ 35 corneum.
, .
:; ~

.
- 12 - J.3n87 P~xamples of skin deliverv enhancers, which can function in a varietv of ways, include:

2-methyl propan-l-ol Propane-1,2-diol Ethyl-2-hydroxypropanoate ~exane-2,5-diol POE(2) ethyl ether Di(2-hydroxypropyl) e~her Pentane-2,4-diol POE(2) methyl ether Tetrahydrofuran ~utane-1,3-diol Propylene glycol dipelar~onate Octyl alcohol POE ester of olevl alcohol Oleyl alcohol Iauryl alcohol Dioctyl adipate Dicapryl adipate Diisopropyl adipate Diisopropyl sebacate Dibutyl sebacate Diethyl sebacate ~5 Dimethyl sebacate Dioctyl sebacate Dibutyl suberate Dioctyl azelate Debenzyl sebacate Dibutyl phthalate Dibutyl azelate Ethyl myristate Dimethyl azelate Butyl myristate Dibutyl succinate Didecyl phthalate ~-` ` `` ` 1 332568 - 13 - J.3087 Decyl oleate ~thyl caproate Ethyl salicylate Ethyl laurate 2-ethyl-hexyl pelargonate Isopropyl isostearate Butyl laurate Benzyl benzoate Butyl benzoate Hexyl laurate Ethvl caprate Ethyl caprylate Butyl stearate ~en~l salicylate ~,lycerol The amount of skin delivery enhancer, when employed -i in accordance with the invention, will normally be from 0.1 to 50%, preferably from 0.5 to 25%i and most preferably ~ from 0.5 to 15% by weight of the emulsion.
:
~ (iv) Perfume ~';
The emulsion according to the invention can also optionally comprise a perfume in an amount sufficient to make the emulsion acceptable to the consumer and pleasant to use. Usually, the perfume when present will form from 0.01 to 10% by weight of the emulsion.
` 30 (v) Further optional ingredients The emulsion according to the invention can also optionally comprise further ingredients in addition to those already described, such as colourants, whiteners, .. ....

: , :
.,;.i .
- 14 - J.3087 preservatives, antioxidants, or aerosol propellants, in amounts which are conventional in the cosmetics art.
pH

The emulsion according to the invention should normally have a p~ value of from 3 to 7, preferably from 3.8 to 5 and ideally from 4 to 4.5.

When the emulsion is an oil-in-water emulsion, the continuous phase being the aqueous phase, then the pH
value can be measured directlv from a p}l electrode placed in the emulsion.

When the emulsion is a water-in-oil emulsion, the continuous phase being the oily phase, then direct pH
measnrement of the emulsion is not possible. In this case, the pH value refers to that of the aqueous phase before emulsifyin~ in the presence of the oily phase.

PRODUCT FORMS AND PACKAGING
-The topical skin treatment emulsion of the invention can be formulated as a fluid, for example in a product such as a ~otion, with or without an applicator such as a " roll-~all applicator, or a propellant-driven aerosol device or a container fitted with a pump to dispense the composition, for example as a mousse or simply for -storage in a non-deformable bottle or squeeze container.
Alternatively, the composition of the invention may be solid or semi-solid, for example a cream or ointment, for use in conjunction with a suitable applicator, or simplv for storage in a tube or lidded jar.
:
More particularly, the viscosity of the emulsion will determine whether it is a lotion or-a cream. For example, x~
- 15 - J.3087 when the viscosity of the emulsion is measured using the ~rookfield Viscometer (lOrpm, measured at 20C usin~
spindles A to ~ as appropriate) then the following viscosity values provide a guide to the nature of the emulsion.

Viscosity tmPas) Description of emulsion up to 2,000 milk 2,000 to 5,000 thin lotion 5,000 to 8,000 normal pourable lotion 8,000 to 10,000 thick lotion*
]0,000 to 15,000 thin cream 15,000 to 30,000 normal cream 30,000 to 100,000 thick cream *dispensible from a squeeze container.

The invention accordinglv also provides a closed container containing a cosmetically acceptable composition as herein defined.

P~EPARATION AND PRODIJCT FORM OF THE EMULSION
., The emulsion of the invention can be prepared in the ` form of a lotion, cream, gel, ointment, solid stick or ` aerosol, or in any other form suited to administration topically to human skin.
.
Accordingly, the invention also provides a process for the preparation of an emulsion suitable for topical application to human skin or hair, which process comprises the steps of:

~' ' ~ ' ~ , , . . .~. ~ . ,. . , , . , ~

1 33256~
- 16 - J.30B7 i. preparinq an aqueous phase, buffered to a p~ value of from 3 to 7, comprising a skin benefit in,gredient as herein defined, preferably a 2-hydroxyalkanoic acid or derivative thereof havinq from 3 to 20 carbon atoms, together with further water-soluble or water-dispersible ingredients as necessar~.

ii. preparing an oily phase comprisin~ emollient oil and polyoxyethylene-21-stearyl ether as emulsifier, together with other oil soluble inqredients;
.~
iii. adding the oily phase prehea~ed to a temperature of at least 70C to the aqueous phase, also preheated to a temperature of at least 70C, with high shear mixing to form an emulsified mixture, iv. cooling the emulsified mixture to a temperature of ' from 35 to 50C and adding the aqueous buffer with ,; low shear mixing;

v. cooling to a temperature of not greater than 35C and ~' adding preservatives and perfume as re~uired with ~, further mixing;
., to obtain emulsion as herein defined.

' FVIDENCE TO DEMONSTRAT~ SUPERIOR STORAGE
STABILITY OF EMULSIONS

, 30 As has been stated earlier, the emulsions of the invention `,~, exhibit superior stability during storaqe at 45C to any '`~ other emulsion containing skin benefit ingredients, such as 2-hydroxyalkanoic acids.

; 35 This superiority was demonstrated using a formulation comprising the principal emulsifier, namely, ` 1 332568 - 17 - J.3087 polyoxyethylene-21-stearyl ether, compared with two similar formulations, in which this principal emulsifier had been replaced bv other emulsifiers.

The basic lotion formulation contained the following ingredients 2-hydroxy alkanoic acids % w/w 2-hydroxv propanoic acid 4.0 2-hydroxy octanoic acid 1.0 Emulsifier as selected* 1.8 Emollient oils lanolin derivative 0.95 wheat~erm oil 0.05 isopropyl myristate 1.0 cetyl palmitate 2.0 wax 2.0 fatty alcohol 1.2 silicone oil 6,0 Thickeners aluminium starch octenyl succinate 3.0 xanthan gum 0.1 Deliver~T enhancer , ~ butane-1,3-diol 9.45 : 35 .

~' .
.', ,:

`` ` 1 332568 - 18 - J.3087 j Other ingredients whitener 0.15 ' preservatives 0.36 '~ 5 water to 100 . Three lotions were prepared based on the above formula:
these were identical except for the emulsifiers which were as follows:
t~ 1 0 ~ Lotion Emulsifier*
:i .
;` A Brii 58 (pol~roxye~hylene-20-cetYl ether) s B Brij 78 (polvoxyethylene-20-stearyl ether) . 15 C Brij 721 (po1~oxyethylene-21-stearvl ether) :
:`
.' I

.~
,i ~:
.
- 19 - J.3087 Results The fcllowing results were obtained after storage:

(i) Stability data The results of storaqe tests at -22C(4 F/T cycles), 20C, 35C and 45C on the three basic lotion models are given in Table 1.
Tah]e 1. Stabilit~ Data for Lotion Models Freeze-Thaw Cycles (x4) Lotion at -22C 20C 35C 45C
;, _______________________________________________________ ____ A Stahle Stable Stable for Stable for ' after for 18 months 1 mth then 1 mth then :- 20 4X oil on then ` surface separated ? --------____________________________________________________ B Stable Stable Stable for Stable for after for 18 months 3 mths then 2 mths then . ~X separated separated ~` ____________________________________________________________ ~ Stable !Stable for 20 Stahle for Stable for after months 13 months 13 months 4X (storage ongoing) _ _ _ _ . ` ' . , ~ . .
~`' . ' , ~
. `? ' . .`
- 20 - J.3087 Table 1 shows that all three lotions survived four freeze-thaw cycles at -22C. With regard to the storage data, there appears to be a trend in the stability conferred by the emulsifiers on the o/w emulsions such that, that containing Brij 721 was clearly far more stable, even when stored at 45~C, than those containing either Brij 78 or Brij 58.

This confir~.ed that Lotion C in accordance with the invention exhibited unexpected superior storage characteristics.

(ii) ~icrostructure of Lotions The microstructure of each lotion was studied 24 hours after preparation, and then after 3 months storage at 20C, and after 6 months storage at 20C. The results obtained are given in Table 2.

,~

, :`
,~
~; .

. : : : , - -: :: :: - ::: : : . .

. ,. , . .. ...... , ..... ,: , ~, .. ,.,.. . :., ~, . : : :

-` 1 332568 - 21 - J.3087 Table 2.
Results from Microstructure Studies (maanification X 100) , _________________________________________________________ Lotion 24 hr after After 3 mths After 6 mths preparation storage at 20C storage at 20C
_________________________________________________________ A Emulsion Flocculation Islets of coalesced appeared and some oil droplets; some stable coalescence phase separation.

B Emulsion Flocculation Coalescence of ~ appeared of oil oil droplets `~ 15 stable droplets _________________________________________________________ , C Emulsion Microstructure No gross changes in : appeared unaltered. microstructure and ` stable. no evidence of Particle flocculation or , size smaller coalscence.
- than for Lotions A
:
`` or B
------------------_-__-_________________ __ ~' The microstructure results reported above provide further evidence to support the finding that the most sta~le `? lotion was Lotion C in accordance with the invention.
(iii) Rheoloqy of lotions All three lotions A, B and C showed some thickening during ~torage see Table 3. Of the three, Lotion C showed the `~ 35 least change after six months storage. The results obtained are given in Table 3.
, . ......................................................................... ..
,: :
., .

~ r,~

`` 1 332568 - 22 - J.3087 Table 3 Viscositv Data using ~rookfield Viscometer .
(at 20C, lOrpm using Spindle B) _______________________________________________________ VISCOSITY
_ ________ _________________________ 24 hr after After 6 mths Lotionspreparation storage at 20C

(mPas~ (mPas) _________________________________ ~ 1200 8400 The viscosity measurements reported above indicate that I,otion C, whose initial viscosity was ideal to enable it to be used as a normal pourable lotion, showed the least change in viscosity during prolonged storage, whereas the comparative Lotions A and B, both of which were too thin ¦ for use 24 hours after preparation, showed unacceptable I increases in viscosity during storage.

~vidence to Demonstrate Increase in Extensibility of Stratum Corneum .

The ability of the emulsion according to the .
invention to enhance the delivery to skin of 2-hydroxyoctanoic acid, as an example of the 2-hydroxy alkanoic acids, or salts thereof, as herein defined, was measured in terms of the increase in extensibility of heat-separated quinea pig foot pad stratum corneum following contact with the emulsion, as compared with another emulsion which did not contain polyoxyethylene-21-stearvl ether.

`` 1 332568 - 23 - J.3087 Tn this experiment, pieces of guinea pig foot pad stratum corneum, equilibrated at a relative humidity of 64%, were immersed in each emulsion or control for 3 hours at 20C, and then removed, blotted dry and re-equilibrated at the same rela~ive humidity. The extensibility of each piece of guinea pig foot pad stratum corneum was measured before and after this treatment in an extensiometer according to the method described in EP-A-0 007 785.

Results The results of this experiment are tabulated below:

Table 4 In Vitro Extensibility Data ~20C, 64% RH) Lotion Extensibility ratio (+2 Standard errors) 6.6 (+1.8) C 8.1 (+1.4) The above results indicate that there is an 23~ increase in extensibility in vitro when the principle emulusifier, as herein defined, is employed (i.e. Lotion C in accordance with the invention), compared with control Lotion A containing an ordinary emulsifier. This confirms significantly enhanced delivery to the stratum corneum of 2-hydroxyoctanoic acid using the emulsion of the invention as compared with a control emulsion.

. .

. . : ~ . . - - : ::: . . - : : .::: .:: , : . :. ~. . .- - : . : .: . . : : . .

``` 1 3325~
- 24 - J.30 EXAMPLES

The invention is further illustrated by the follo~ring examples.
Example 1.

This example illustrates an oil-in-water skin cream according to the invention.

% w/w Skin benefit ingredients 2-hydroxypropanoic acid 4.0 2-hvdroxyoctanoic acid 1.0 Principal emulsifier polyoxyethylene-21-stearyl ether 2.4 ~ .
Secondary emulsifier polyoxyethylene-2-stearyl ether 2.6 ~:
~ mollient oils ,`'! polyoxypropylene-15-stearyl ether 8.0 fatty alcohol 4.0 i` 25 silicone oil 0.1 i, ~elivery enhancer ~ butane-1,3-diol 5.0 ,:, 30 Other ingredients ~` preservative 0.36 pH adiustant 3.36 ~' perfume 0.1 ! water 69,08 , 35 100.00 .i.
~' ~
. The cream had a pH value of 4.

.

`` 1 332568 :
- 25 - J.3087 Example 2 Thi~ example illustrates an oil-in-water skin lotion according to the invention.

% w/w Skin benefit ingredients 2-hydroxy propanoic acid 4.0 2-hydroxy octanoic acid 1.0 Principal emulsifier polyoxyethylene-21-stearyl ether 1.8 Emollient oils lanolin derivative 0.95 wheatgerm oil 0.05 isopropyl myristate 1.0 cetyl palmitate 2.0 wax 2.0 fatty alcohol 1.2 :.
silicone oil 6.0 . .
Thickeners Aluminium starch octenyl succinate 3.0 xanthan gum 0.1 Delivery enhancer butane-1,3-diol 9.45 : 30 Other_ingredients : whitener 0.15 preservatives 0.36 pH adjustant 3.36 perfume 0.1 water 63.48 100.00 The lotion had a pH value of 4.
., 1 33256~
- 26 - J.3087 .

Viscosity: Brookfield Viscometer, lOrpm, Spindle B
measured at 20C.

5 Storage time: 24 hrs 6 months viscosity (in mPas) 6000 7200 "
., .
. ~
- 27 - J.3087 Example 3 This example illustrates on oil-in-water fluid skin cream according to the invention.

~ w/w Skin benefit in~redlents 2-hydroxy propanoic acid 4.0 2-hydroxy octanoic acid 1.0 lC
Principal emulsifier polyoxyethylene-21-stearyl ether l.B -~mollient oils lano~.in derivative 0.95 wheat germ oil 0.05 cetvl palmitate 2.0 isopropyl myristate 1.0 wax 3 0 fatty alcohol 1.2 - silicone oil 5.0 Thickeners .
aluminium starch octenyl succinate 3.0 xanthan gum 0.1 '~
- Delivery enhancer butane-1,3-diol 9.45 30 Other ingredients :
whiteners 0.15 preservative 0.36 pH adjustant 3.36 ~' perfume 0.1 water 63.48 100.00 The emulsion had a pH value of 4.

' .
28 - J.3087 Viscosity: Rrookfield Viscometer, lOrpm, Spindle B
measured at 2QC.

5 Storage time: 24 hrs 13 weeks Viscosity (mPas) 5800 22,000 ;.
:, :

:~` 1 332568 - 29 J.3087 Example 4 !

This example illustrates an oil-in-water skin cream according to the invention. %wlw ~ Skin benefit ingredients ; 5 2-hvdroxy propanoic acid 4.0 2-hydroxyoctanoic acid 1.0 Principle emulsifier polyoxyethylene-21-stearyl ether0.94 Secondary emulsifier polyoxyethylene-2-stearyl ether 0.86 Emollient oils lanolin derivative 0.95 - whe~t germ oil 0.05 isopropyl myristate 1.0 cetyl palmitate 2.0 ozokerite wax 3.0 fattv alcohol 1.2 silicone oil 5.0 Thickeners -. aluminium starch octenyl succinate 3.0 xanthan gum 0.1 ` Delivery enhancer ` ~utane-1,3-Ziol 9.45 Other ingredients`
30 whitener 0.15 preservatives 0.36 pH adjustant 3.36 perfume 0.1 water 63.48 100.00 The cream had a pH value of 4.

- 30 - J.3087 Viscosity: Brookfield Visc~meter, lOrpm, Spindle D
measured at 20C.

5 Storage time: 24 hrs Viscosity ~mPas) 50,000 .

, .
, .

``` ` 1 332~68 - 31 - ~ ;

Fxample 5 This example illustrates~ an oil-in-water skin ~ n accordin~ to the invention.
s ...~

Skin benefit ingredient hydrocortisone acetate Principal Emulsifier polyoxyethylene-21-stearyl ether Secondary Emulsifier 15 polyoxyethylene-2-stearyl ether 0 Emollient ~ils isopropyl myristate 2.,~
cetyl palmitate ~ 3!1, 20 wax 2,~'s~
fatty alcoh~
silicone oil St.

Thickener 25 xanthan gum 0 i~
.~ :
Deliverv enhancer ., - butane-1,3-diol 13 .~
!
30 Other ingredients whitener t.
preservatives 0 water to 100 " 35 The cream will have a pH value of from 3 to 7.

.. .. .
.

., :
- 32 - J.3087 Example 6 This example illustrates an oil-in-water skin lotion according to the invention.
: 5 ~ w/w ~kin benefit in~redients Tocopherol 0.20 Ascorbic acid 0.30 Principal Emulcifier polyoxyethylene-21-stearyl ether 1.80 Emollient oils `` 15 avocado oil 0.50 arnica oil 0.50 isopropyl myristate 2.00 ~` cetyl palmitate 2.00 wax 2.00 1 2n ~atty alcohol 1.20 `. silicone oil 6.00 ~ .
Thickeners alumi~ium starch octenyl succinate 3.00 25 xanthan gum 0.l0 Delivery enhancer butane-1,3-diol 7.50 3n Other Ingredients whitener 0.20 preservatives 0.36 perfume 0.10 water to 100 `35 : The lotion will have a pH value of from 3 to 7. `
. ....

~` . .

`` ~ 1 3 3 2 5 68 _ 33 _ J.3087 ExamPle 7 This example illustrates an oil-in-water emulsion according to the invention.

% w/w Skin benefit in~redients retinyl palmitate 0.10 octyl methoxy cinnamate 3.00 10 butylmethoxydibenzoylmethane 1.50 ; Emulsifiers polyoxyethylene-21-stearyl ether2.40 polyoxyethylene-2-stearyl ether 2.60 Emollient oils wheatgerm oil 0.10 ` caprylic/capric triglvcerides 5.00 ! silicone oil 2.50 `. 20 evening primrose oil 0.40 : elivery enhancer glycerol 5.00 25 Other ingredients ~ allantoin 0.50 :~ preservatives 0.36 ` perfume 0.15 water ` to 100%
` 30 ~ ` :
~ The emulsion will have a pH value of from 3 to 7.

:

::`
`~`

: . ~ . - . .: .-. . ~ ~ ~ . ; . - . .

~ `' - ~ 1 332~68 - 34 - J.3087 Example 8 This example illustrate an oil-in-water emulsion according to the invention.
S
% w/w Skin benefit ingredients ~, L-proline 0.1 octyl methoxycinnamate i Emulsifiers ~a polyoxyethylene-21-stearyl ether 3 polvoxyethylene-2 stearvl ether 2 15 Emollient oils stearyl alcohol polyoxypropylene-15-stearyl ether 10 ~ilicone oil 0.5 evening primrose oil Delivery enhancer propane-1,4-diol 4 Other in~redients 25 preservative and perfume qs water to 100 This emulsion will have a pH value of from 3 to 7.

'~

:
, .

Claims (12)

1. An emulsion suitable for topical application to human skin or hair, which comprises in addition to water:

i. from 0.01 to 20% by weight of a skin benefit ingredient chosen from Retinoic acid Retinyl palmitate Ascorbic acid Ascorbyl palmitate Tocopherol Tocopherol acetate Pyroglutamic acid and salts thereof Amino acids Sunscreens Hyaluronic acid and salts thereof Perfluoropolyether Hydrocortisone acetate, and a
2-hydroxyalkanoic acid having from 3 to 20 carbon atoms, or a salt thereof; and mixtures thereof.

ii. from 0.1 to 20% by weight of polyoxyethylene-21-stearyl ether, as a principle emulsifier; and iii. from 0.5 to 70% by weight of an emollient oil.

2. An emulsion according to claim 1, in which the amino acid is chosen from:

glycine alanine valine leucine isolencine phenylalanine tyrosine proline hydroxyproline serine threonine cysteine cystine methionine tryptophan aspartic acid glutamic acid arginine lysine, and histidine and mixtures thereof.
3. An emulsion according to claim 1, in which the sunscreen is chosen from:

p-Aminobenzoic acid Ethyl dihydroxypropyl p-aminobenzoic acid Glyceryl p-aminobenzoic acid 2,4-Dihydroxy benzophenone 2-Ethoxyethyl-p-methoxycinnamate Di-ethanolamine p-methoxycinnamate 2-Ethylhexyl salicylate Homomenthyl salicylate 2-Phenylbenzimidazole-5-sulphonic acid Ethylhexyl p-methoxycinnamate 3-(4-Methylbenzylidine) camphor 2-Hydroxy-4-methoxy benzophenone Butylmethoxydibenzoylmethane, and
4-isopropyl dibenzoylmethane.

4. An emulsion according to claim 1, in which the 2-hydroxyalkanoic acid is chosen from 2-hydroxypropanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyoctanoic acid and mixtures thereof.
5. An emulsion according to claim 1, 3 or 4, in which the 2-hydroxyalkanoic acid salt is chosen from the sodium, potassium and triethanolamine salts.
6. An emulsion according to claim 1, 3 or 4, in which the amount of the skin benefit ingredient is from 0.1 to 10% by weight of the emulsion.
7. An emulsion according to claim 1,3 or 4, in which the amount of polyoxyethylene-21-stearyl alcohol is from 0.5 to 10% by weight of the emulsion.
8. An emulsion according to claim 1, 3 or 4, in which the emollient oil is chosen from:

polyoxypropylene-15-stearyl ether dimethylpolysiloxanes lanolin cetyl alcohol stearyl alcohol wheatgerm oil isopropyl myristate cetyl palmitate evening primrose oil arnica oil avacado oil caprylic and capric triglycerols ozokerite wax, and mixtures thereof.
9. An emulsion according to claim 1, 3 or 4, in which the amount of the emollient oil is from 1 to 60% by weight of the emulsion.
10. An emulsion according to claim 1, 3 or 4, which further comprises a secondary emulsifier chosen from:

polyoxyethylene-2-stearyl ether polyoxyethylene-2-cetyl ether, and a mixture thereof.
11. An emulsion according to claim 1, 3 or 4, which further comprises a delivery enhancer chosen from:

butane-1,3-diol, glycerol propane-1,4-diol, dibutyl sebacate, and mixtures thereof.
12. An emulsion according to claim 1, 3 or 4, which further comprises a perfume.
CA000610359A 1988-09-09 1989-09-05 Cosmetic composition Expired - Fee Related CA1332568C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8821129.7 1988-09-09
GB888821129A GB8821129D0 (en) 1988-09-09 1988-09-09 Cosmetic composition

Publications (1)

Publication Number Publication Date
CA1332568C true CA1332568C (en) 1994-10-18

Family

ID=10643292

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000610359A Expired - Fee Related CA1332568C (en) 1988-09-09 1989-09-05 Cosmetic composition

Country Status (11)

Country Link
US (1) US4981845A (en)
EP (1) EP0358528B1 (en)
JP (1) JPH0684291B2 (en)
KR (1) KR900004319A (en)
AT (1) ATE107160T1 (en)
AU (1) AU622478B2 (en)
CA (1) CA1332568C (en)
DE (1) DE68916137T2 (en)
ES (1) ES2056220T3 (en)
GB (1) GB8821129D0 (en)
ZA (1) ZA896885B (en)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903483A0 (en) * 1989-07-13 1990-07-10 Bristol Myers Squibb Co TRETINOIN INNEHAOLLANDE STABILA EMULSIONSKRAEMFORMULATIONER.
GB9010525D0 (en) * 1990-05-10 1990-07-04 Unilever Plc Cosmetic composition
FR2675692A1 (en) * 1991-04-24 1992-10-30 Oreal ANTI-OXIDANT SYSTEM CONTAINING PYRROLIDONE CARBOXYLATE LYSINE AND / OR ARGININE PYRROLIDONE CARBOXYLATE EITHER BEING ASSOCIATED WITH A PHENOLIC DERIVATIVE AND ITS USE IN COSMETICS.
US5431913A (en) * 1992-01-24 1995-07-11 Phillips; Eva J. Skin cleansing and exfoliant composition and method of treating skin
GB9204509D0 (en) * 1992-03-02 1992-04-15 Unilever Plc Hair care composition
SK279919B6 (en) * 1993-07-01 1999-05-07 Yamanouchi Europe B.V. PHARMACEUTICAL AND COSMETIC MEDICINAL PRODUCTS
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
US5407678A (en) * 1993-09-01 1995-04-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly cream
JP3492738B2 (en) * 1993-10-13 2004-02-03 サンスター株式会社 Hair cosmetics
DE4345186C2 (en) * 1993-12-27 1997-08-14 Galderma Sa Hydrocortisone 21-acetate-17-propionate containing W / O lotions
DE4344697A1 (en) * 1993-12-27 1995-06-29 Beiersdorf Ag New lotion is water-oil emulsion compsn. contg. corticosteroid
GB9414573D0 (en) * 1994-07-19 1994-09-07 Unilever Plc Detergent composition
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
BE1009380A3 (en) * 1995-03-14 1997-03-04 Universiteit Gent Lab Voor Far Stabilizing COMPOSITION FOR SUSPENSION.
WO1997001322A1 (en) * 1995-06-26 1997-01-16 Hans Schwarzkopf Gmbh Hair care products with at least one conditioner
DE19617515A1 (en) * 1995-06-26 1997-01-02 Schwarzkopf Gmbh Hans Conditioning hair treatment agent contg. aminoacid or peptide
US5691380A (en) * 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
FR2737119B1 (en) * 1995-07-25 1997-09-12 Oreal SILICONE COMPOSITION CONTAINING A WATER SENSITIVE ACTIVE INGREDIENT
DE19615041A1 (en) * 1996-04-17 1997-10-23 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing triazine derivatives and alkyl esters and / or dialkyl esters of alpha, omega-alkanedicarboxylic acids
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
DE19724587A1 (en) * 1997-02-15 1998-12-24 Wella Ag Hair care products
DE19713776A1 (en) * 1997-04-03 1998-10-08 Beiersdorf Ag Light protection preparations with a content of basic amino acids and water-soluble UV filter substances
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
ITMI981579A1 (en) * 1998-07-10 2000-01-10 Condea Augusta Spa DETERGENT COMPOSITION WITH SOFTENING AND PROTECTIVE ACTION OF NATURAL FIBERS
ES2432691T3 (en) * 1999-04-23 2013-12-04 Leo Pharma A/S Pharmaceutical composition for dermal use comprising calcipotril and betamethasone for the treatment of psoriasis
US6864274B2 (en) 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6896897B2 (en) * 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6281236B1 (en) 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US6531500B2 (en) 1999-07-23 2003-03-11 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6329413B1 (en) 1999-07-23 2001-12-11 Alwyn Company, Inc. Allantoin-containing skin cream
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
KR100688910B1 (en) * 2000-07-06 2007-03-08 주식회사 코리아나화장품 Tripeptide-containing lipstick composition
US6719964B1 (en) * 2001-07-07 2004-04-13 Premier Specialties Inc. Compositions for prevention of chemically induced irritation and discolorations and methods of using same
US20030215475A1 (en) * 2002-03-19 2003-11-20 Shah Anil N. Dry feeling low spreading emollient gel
EP1523300B1 (en) * 2002-07-22 2007-10-03 Unilever N.V. Hair care method characterised by application of specific 2-hydroxyalkanoic acids
AU2003281485A1 (en) * 2002-07-22 2004-02-09 Unilever Plc Hair care composition
JP2004075549A (en) * 2002-08-12 2004-03-11 Kanebo Ltd Cosmetic
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
NZ540166A (en) * 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CA2534372C (en) * 2003-08-04 2012-01-24 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
JP2006131585A (en) * 2004-11-09 2006-05-25 Nippon Fine Chem Co Ltd Hair cosmetics
US20060120980A1 (en) * 2004-12-02 2006-06-08 Eberl James J Novel dermatological composition using bio-activating organocatalysts
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
JP2007262035A (en) * 2006-03-30 2007-10-11 Nikko Chemical Co Ltd Cosmetic for hair restoration
JP4809161B2 (en) * 2006-08-29 2011-11-09 富士フイルム株式会社 Topical skin preparation
CN101563058A (en) * 2006-09-08 2009-10-21 弗米克斯有限公司 Colored or colorable foamable composition and foam
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
JP5168996B2 (en) * 2007-04-13 2013-03-27 味の素株式会社 Preserved aqueous solution with high amino acid content
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090558A2 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8425882B2 (en) * 2008-04-01 2013-04-23 Conopco, Inc. In-shower and bath compositions
US8299127B2 (en) * 2009-03-11 2012-10-30 Conopco, Inc. Method and composition for evenly applying water soluble actives
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
JP5830285B2 (en) * 2011-07-08 2015-12-09 花王株式会社 Emulsion composition for hair treatment
DK2744519T3 (en) 2011-08-16 2019-01-21 Kate Somerville Skincare Llc COMPOSITIONS FOR SKIN REINFIGURATION
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
JP5826075B2 (en) * 2012-03-08 2015-12-02 株式会社ナリス化粧品 Cosmetics
US9808435B2 (en) * 2013-03-12 2017-11-07 Ecolab Usa Inc. Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
DE102013217025A1 (en) * 2013-08-27 2015-03-05 Henkel Ag & Co. Kgaa "Products for oxidative color change of keratin fibers in the donor"
JP6591745B2 (en) * 2014-12-08 2019-10-16 ロレアル Cosmetic composition for keratin fibers and process for producing the same
US20170296460A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US10493020B2 (en) * 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US20170296459A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
MX377365B (en) 2016-09-08 2025-03-10 Journey Medical Corp COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE.
KR101955703B1 (en) * 2017-04-28 2019-03-07 주식회사 가인화장품 Cosmetic composition for hair care and hair caring method using the same
WO2020126659A1 (en) * 2018-12-19 2020-06-25 Unilever Plc Hair conditioning composition for improved deposition
US20200197274A1 (en) * 2018-12-21 2020-06-25 L'oréal Anhydrous makeup removing composition
FR3090341B1 (en) * 2018-12-21 2020-12-04 Oreal COMPOSITION CONSISTING OF A BODY FAT, A PEG POLYMER, A DIOL AND A POLYSACCHARIDE
US20210059915A1 (en) * 2019-08-30 2021-03-04 L'oreal Cosmetic composition having a lamellar network
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
US20210401702A1 (en) * 2020-06-30 2021-12-30 L'oreal Cosmetic composition providing unique sensations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
BR7904612A (en) * 1978-07-24 1980-04-08 Unilever Nv COMPOSITION COSMETICALLY ACCEPTABLE FOR TOPICAL APPLICATION, PROCESS TO PREPARE A COMPOSITION, APPLICATOR AND PROCESS TO PROVIDE SKIN ADVANTAGE
GB8302683D0 (en) * 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
US4567038A (en) * 1985-03-06 1986-01-28 Revlon, Inc. Sunscreen composition for hair protection
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
EP0496434B1 (en) * 1987-10-22 1999-02-03 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
WO1989010738A1 (en) * 1988-05-09 1989-11-16 Solarcare, Inc. Sunscreen composition and applicator system

Also Published As

Publication number Publication date
DE68916137T2 (en) 1994-12-01
KR900004319A (en) 1990-04-12
US4981845A (en) 1991-01-01
AU622478B2 (en) 1992-04-09
EP0358528B1 (en) 1994-06-15
GB8821129D0 (en) 1988-10-12
JPH02121906A (en) 1990-05-09
EP0358528A3 (en) 1991-04-03
DE68916137D1 (en) 1994-07-21
JPH0684291B2 (en) 1994-10-26
ES2056220T3 (en) 1994-10-01
EP0358528A2 (en) 1990-03-14
AU4120689A (en) 1990-03-15
ZA896885B (en) 1991-05-29
ATE107160T1 (en) 1994-07-15

Similar Documents

Publication Publication Date Title
CA1332568C (en) Cosmetic composition
JP3609834B2 (en) Skin preparation
EP0058853B1 (en) Skin care composition
US5008100A (en) Oil-in-water emulsions containing polyethylene
US5310556A (en) Cosmetic composition
KR890004681B1 (en) Microemulsion composition moisturizes the skin
US6264963B1 (en) Skin care composition with improved skin hydration capability
US20200405604A1 (en) Cosmetic composition comprising 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone
US5720948A (en) Non-ionic surfactant emulsion vehicles and their use for deposition of drug into and across skin
US20100316581A1 (en) Skin External Preparations
US4337241A (en) Emulsions of the water-in-oil or oil-in-water type and cosmetic products using these emulsions
US4939179A (en) Cosmetic emulsions with hydrocarbon thickening agents
EP0009404A2 (en) Water-in-oil emulsions and process for preparing them
US20020094341A1 (en) Skin moisturizer compositions containing a sebum control agent
AU687502B2 (en) Dermatologic composition
WO2001006993A1 (en) Oil-in-water emulsion composition
JP2002518154A (en) Flowable preparation of water-in-oil emulsion with high water content
JP2002518153A (en) Flowable preparation of water-in-oil emulsion with high water content
US5807561A (en) Emulsifying system for a whitening cosmetic composition
JP3434864B2 (en) High moisture retention emulsified composition
JPH11505811A (en) Cosmetics to prevent and correct skin damage
WO2004050010A2 (en) Composition, especially a cosmetic composition, containing at least one alkyl para-hydroxybenzoate and at least one lipophilic amino acid derivative
JPH0615449B2 (en) External water phase type cosmetics
JP2002308962A5 (en)
JPH09249547A (en) Water-in-oil emulsion composition

Legal Events

Date Code Title Description
MKLA Lapsed